upgrade

The firm cited the stabilization of slowing revenue growth and the company's long-term growth plans.

Price target was set at $65.

Barrington reportedly upgraded Vistaprint (VPRT) to Outperform from Market Perform.

The firm upgraded the company's shares based on valuation and checks that indicate healthy industry EMS trends.

Price target is set at $15.

Collins Stewart reportedly upgraded Celestica (CLS) to Buy from Neutral.

There is potential upside of 8.1% in shares of Sinclair Broadcast Group based on a current price of $12.22 and an average consensus analyst price target of $13.22. Sinclair Broadcast Group shares have support at the 50-day moving

One week ago Sinclair Broadcast Group (NASDAQ:SBGI) was upgraded from Market Perform to Outperform at Wells Fargo. The stock closed at $12.17, which is 27.2% higher than the price one week ago ($9.57).

athenahealth (NASDAQ:ATHN) defies analysts with a current price ($48.07) 23.7% above its average consensus price target of $36.69. The stock should discover initial support at its 50-day moving average (MA) of $43.32 and subsequen

One week ago athenahealth (NASDAQ:ATHN) was upgraded from Market Perform to Outperform at Wells Fargo. The stock closed at $47.44, which is 2.8% higher than the price one week ago ($46.13).

The bank sees 2011 EPS of $0.77, down from $0.86 per share, and 2012 EPS of $1.28, up from $1.12 per share.

OpenTable is currently above its 50-day moving average (MA) of $75.14 and above its 200-day of $57.89.

Morgan Stanley adjusted its 2011 and 2012 EPS estimates for OpenTable (NASDAQ:OPEN) and maintained its equal-weight rating.

The company posted record revenue of $33.8 million for the fourth quarter ended Dec. 31, a 29% increase over the $26.2 million reported for the same period in 2009. Net income was $4.3 million for the fourth quarter, or $0.20 per

Shares of Stratasys (SSYS) are up $4.80 to $40.18, or 11.61%, after the company reported strong fourth quarter and full year financial results that surpassed market expectations.

Morgan Stanley lowered its 2011 and 2012 EPS estimates for Teva Pharmaceutical Industries (NASDAQ:TEVA) and maintained its equal-weight rating. The bank sees 2011 EPS of $5.05, down from $5.29 per share, and 2012 EPS of $5.78, do

Morgan Stanley lowered its 2011 and 2012 EPS estimates for Sara Lee (NYSE:SLE) and maintained its equal-weight rating and $14.50 price target. The bank sees 2011 EPS $0.85, down from $0.89 per share, and 2012 EPS of $1.00, down fr

The firm made the call based on valuation and a likely difficult Q4 due to weather and tax refund delays.

Dick's Sporting is down nearly 2% early Wednesday on the news, at $37.55.

Shares of Dick's Sporting (DKS) are down in pre-market trading as the company was reportedly downgraded to Hold from Buy at ThinkEquity.

The bank sees 2012 EPS of $1.98, up from $1.97 per share.

Illumina has a potential upside of 5% based on a current price of $70.25 and an average consensus analyst price target of $73.73.

Illumina is currently above its 50-day moving average (MA) of $66.13 and above its 200-day of $51.55.

Morgan Stanley raised its 2012 EPS estimate for Illumina (NASDAQ:ILMN) and maintained its overweight rating and $78 price target.